CROCO (CROhn's Disease COhort Study) - 研究計画とプロトコルについて
Joana Revés1, Anthony Buisson2, Johan Burisch3,4,5
1Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal.
Therapeutic advances in gastroenterology
|September 2, 2025
まとめ
この研究では,レマン指数 (LI) を用いて,クローン病 (CD) 患者における腸損傷の進行を追跡した. 発見は病気の進化を予測し,炎症性腸疾患の治療戦略を伝えるのに役立ちます.
科学分野:
- 胃腸内科
- 炎症性腸疾患の研究
- 臨床試験の方法論
背景:
- クローン病 (Crohn's disease,CD) は慢性的な炎症性疾患で,大腸の損傷と障害を引き起こす.
- レマン指数 (LI) はCDにおける累積的な腸損傷を測定し,ストリチュリング,穿透,および外科的損傷を評価します.
- 新規に診断されたCD患者の腸損傷の進行に関する予測データは限られている.
研究 の 目的:
- 最近診断されたCD患者の5年間の腸損傷の進行をLIを用いて特徴づける.
- 腸の損傷の進行と現象型,治療,バイオマーカー,障害などの病気の特徴の関係を評価する.
- 腸の損傷の進行と障害との関連を予測する要因を確立する.
主な方法:
- クローン病コホート研究 (CROCO研究) は,将来的な多中心のヨーロッパコホート研究です.
- 12ヶ月以内に診断されたCD患者は5年間,標準的な治療を受けています.
- LIと障害 (IBD-DI) は間隔で評価されます.
主要な成果:
- 研究が進行中なので,このセクションはまだ利用できません.
- 腸の損傷の縦断的な変化を評価するためにデータ収集と分析が進行中です.
- この研究は,CDの進行に影響を与える主要な要因を特定することを目的としています.
結論:
- CROCOの研究は,CDの自然史と進化を理解するためのユニークなデータセットを提供します.
- 発見は,腸の損傷の進行を予測するスコアを開発するのに役立ちます.
- この研究はCD治療のための将来の臨床試験の設計を支援します.
さらに関連する動画
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.4K
08:02Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
Published on: March 12, 2020
6.7K
関連する概念動画
01:20Study Designs in Epidemiology
410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410
01:30Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
01:16Crossover Experiments
3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K